Skip to main content
An official website of the United States government

PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Sponsor
University of California, San Francisco
Status
Not yet recruiting
NCT ID
NCT06949800
This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population
Intervention
EXE-346 Probiotic, Placebo, Usual Care High Resolution Anoscopy (HRA)
Condition
HSIL, High Grade Squamous Intraepithelial Lesion, HPV-Related Squamous Cell Carcinoma, Anal HSIL
Investigators
Joel Palefsky, MD, Salim Abraham Barquet-Munoz, MD,MSc, PhD, Ana Patricia Ortiz Martinez, MPH, MD
CT Research Area
Prevention

See list of participating sites